Control of NOD2 and Rip2-Dependent Innate Immune Activation by GEF-H1

Inflammatory Bowel Diseases

Volumn 18, Issue 4, 2012, Pages 603-612

  Zhao, Yun ^a   Alonso, Carmen ^a   Ballester, Isabel ^a   Song, Joo Hye ^a   Chang, Sun Young ^a   Guleng, Bayasi ^a   Arihiro, Seiji ^a   Murray, Peter J ^b   Xavier, Ramnik ^a   Kobayashi, Koichi S ^c   Reinecker, Hans Christian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Crohn's disease; Innate immune regulation; NOD like receptors; Src kinase; Tyrosine phosphorylation

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; GUANINE NUCLEOTIDE EXCHANGE FACTOR H1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; RIP2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HCT116; CELL STRAIN HEK293; CROHN DISEASE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INNATE IMMUNITY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CROHN DISEASE; CYTOKINES; GENE KNOCKDOWN TECHNIQUES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HCT116 CELLS; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; SRC-FAMILY KINASES;

EID: 84858702357     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21851     Document Type: Article

References (43)

1. Stuart LM, Ezekowitz RA. Phagocytosis and comparative innate immunity: learning on the fly. Nat Rev Immunol. 2008;8:131-141. (Pubitemid 351161303)
2. Glaven JA, Whitehead I, Bagrodia S, et al. The Dbl-related protein, Lfc, localizes to microtubules and mediates the activation of Rac signaling pathways in cells. J Biol Chem. 1999;274:2279-2285.
3. Krendel M, Zenke FT, Bokoch GM. Nucleotide exchange factor GEFH1 mediates cross-talk between microtubules and the actin cytoskeleton. Nat Cell Biol. 2002;4:294-301. (Pubitemid 34308855)
4. Fukazawa A, Alonso C, Kurachi K, et al. GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors. PLoS Pathog. 2008;4:e1000228.
5. Inohara, Chamaillard, McDonald C, et al. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem. 2005;74:355-383.
6. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem. 2003;278:5509-5512. (Pubitemid 36800790)
7. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869-8872. (Pubitemid 36800360)
8. Archer KA, Ader F, Kobayashi KS, et al. Cooperation between multiple microbial pattern recognition systems is important for host protection against the intracellular pathogen Legionella pneumophila. Infect Immun. 2010;78:2477-2487.
9. Shimada K, Chen S, Dempsey PW, et al. The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection. PLoS Pathog. 2009;5:e1000379.
10. Duan W, Mehta AK, Magalhaes JG, et al. Innate signals from Nod2 block respiratory tolerance and program T(H)2-driven allergic inflammation. J Allergy Clin Immunol. 2010;126:1284-1293.
11. Biswas A, Liu YJ, Hao L, et al. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A. 2010;107:14739-14744.
12. Yang Y, Yin C, Pandey A, et al. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J Biol Chem. 2007;282:36223-36229.
13. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine- rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603. (Pubitemid 32531408)
14. Duerr RH, Barmada MM, Zhang L, et al. Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage. Hum Mol Genet. 2002;11:2599-2606. (Pubitemid 35189520)
15. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606. (Pubitemid 32531409)
16. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731-734. (Pubitemid 40194644)
17. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53:1658-1664. (Pubitemid 39434112)
18. Watanabe T, Kitani A, Murray PJ, et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol. 2004;5:800-808. (Pubitemid 39172973)
19. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19-20. (Pubitemid 32801800)
20. Rahman P, Bartlett S, Siannis F, et al. CARD15: a pleiotropic auto-immune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet. 2003;73:677-681. (Pubitemid 37076282)
21. Kobayashi K, Inohara N, Hernandez LD, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 2002;416:194-199. (Pubitemid 34246479)
22. Inohara N, del Peso L, Koseki T, et al. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J Biol Chem. 1998;273:12296-12300. (Pubitemid 28240597)
23. Thome M, Hofmann K, Burns K, et al. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol. 1998;8:885-888. (Pubitemid 28356050)
24. Meylan E, Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci. 2005;30:151-159. (Pubitemid 40332531)
25. McCarthy JV, Ni J, Dixit VM. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem. 1998;273:16968-16975. (Pubitemid 28311729)
26. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 2003;124:993-1000. (Pubitemid 36389802)
27. Oppermann FS, Gnad F, Olsen JV, et al. Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics. 2009;8:1751-1764.
28. Fan H, Teti G, Ashton S, et al. Involvement of G(i) proteins and Src tyrosine kinase in TNFalpha production induced by lipopolysaccharide, group B Streptococci and Staphylococcus aureus. Cytokine. 2003;22:126-133. (Pubitemid 36808758)
29. Orlicek SL, Hanke JH, English BK. The src family-selective tyrosine kinase inhibitor PP1 blocks LPS and IFN-gamma-mediated TNF and iNOS production in murine macrophages. Shock. 1999;12:350-354.
30. Smolinska MJ, Horwood NJ, Page TH, et al. Chemical inhibition of Src family kinases affects major LPS-activated pathways in primary human macrophages. Mol Immunol. 2008;45:990-1000. (Pubitemid 350017845)
31. Tigno-Aranjuez JT, Asara JM, Abbott DW. Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses. Genes Dev. 2010;24:2666-2677.
32. Stronati L, Negroni A, Merola P, et al. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease. Inflamm Bowel Dis. 2008;14:295-302. (Pubitemid 351441316)
33. Negroni A, Stronati L, Pierdomenico M, et al. Activation of NOD2- mediated intestinal pathway in a pediatric population with Crohn's disease. Inflamm Bowel Dis. 2009;15:1145-1154.
34. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434. (Pubitemid 47123518)
35. Chin AI, Dempsey PW, Bruhn K, et al. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature. 2002;416:190-194. (Pubitemid 34246478)
36. Kamon H, Kawabe T, Kitamura H, et al. TRIF-GEFH1-RhoB pathway is involved in MHCII expression on dendritic cells that is critical for CD4 T-cell activation. Embo J. 2006;25:4108-4119. (Pubitemid 44338751)
37. Shibolet O, Giallourakis C, Rosenberg I, et al. AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling. J Biol Chem. 2007;282:35308-35317. (Pubitemid 350232485)
38. Stovall SH, Yi AK, Meals EA, et al. Role of vav1- and src-related tyrosine kinases in macrophage activation by CpG DNA. J Biol Chem. 2004;279:13809-13816. (Pubitemid 38468912)
39. Page TH, Smolinska M, Gillespie J, et al. Tyrosine kinases and inflammatory signalling. Curr Mol Med. 2009;9:69-85.
40. Severgnini M, Takahashi S, Tu P, et al. Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury. Am J Respir Crit Care Med. 2005;171:858-867. (Pubitemid 40562716)
41. Bain J, Plater L, Elliott M, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007;408:297-315.
42. Breza N, Pato J, Orfi L, et al. Synthesis and characterization of novel quinazoline type inhibitors for mutant and wild-type EGFR and RICK kinases. J Recept Signal Transduct Res. 2008;28:361-373.
43. Brehmer D, Greff Z, Godl K, et al. Cellular targets of gefitinib. Cancer Res. 2005;65:379-382.